Tumor of fibroblastic reticular cells of lymph node coincidental with an undifferentiated endometrial stromal sarcoma. Report of a case with distinctive immunophenotype and Kikuchi‐like necro‐inflammatory response
D. Suárez,F. Izquierdo,J. R. Méndez,Juliana Escobar,A. Cabeza,P. Junco
DOI: https://doi.org/10.1111/j.1600-0463.2010.02712.x
2011-03-01
Abstract:Sir: Tumors of fibroblastic reticular cells (TFBRs) are very uncommon neoplasms whereof less than 20 cases have been described (1–10). We report a TFBR of the lymph node, simultaneously diagnosed with an undifferentiated endometrial stromal sarcoma of the uterus. This TFBR presented a distinctive immunophenotype and a necro-inflammatory intratumoral response, similar to that of the Kikuchi’s disease (11). A 71-year-old woman was sent to our hospital because of postmenopausal metrorrhages. Upon hysteroscopy, a polypoid tumor filling the entire uterine cavity was found. In October 2009, a total hysterectomy including both adnexa was performed. A lymph node of the chain of the right external iliac vein showed a tumoral appearance. After the diagnosis of uterine undifferentiated endometrial stromal sarcoma and TFBR of the lymph node, additional pelvic radiotherapy was implemented. In April 2010, the patient showed multiple implants of the uterine tumor inside the abdominal cavity. Microscopically, the uterine neoplasm showed spindle cells with wide, clear or lightly eosinophilic cytoplasm, ovoid elongated nuclei and small nucleoli (Fig. 1A). The mitotic rate was 50–60 per 10 high-power fields (HPF). Tumor necrosis was abundant and accompanied by an infiltrate of neutrophilic leukocytes. The node of the left iliac chain was widely occupied by a different tumor, made up by epithelioid cells with wide eosinophilic cytoplasm with diffuse border. Their nuclei showed open chromatin and prominent eosinophilic nucleoli (Fig. 1B). The mitotic rate was 25–30 per 10 HPFs with some atypical forms. The neoplastic cells were enmeshed with an abundant inflammatory infiltrate composed of lymphocytes, histiocytes and isolated plasma cells. Some tumor and inflammatory cells displayed apoptotic changes. Areas of coagulative necrosis with geographic contour, delimited by palisades of tumor cells enmeshed with lymphocytes and histiocytes, were present (Fig. 1C). In the necrotic foci and in the entire tumor, neutrophilic infiltrates were absent. At the immunohistochemical study (Table 1), the tumor of the lymph node showed diffuse staining for vimentin, CK18, CK AE1-AE3, CD10, WT1 (cytoplasmic), CD38, D2-40 (podoplanin), CNA-42, and a-1-antitrypsin. Isolated elements stained for epithelial membrane antigen (EMA) (Fig. 1D–F). More than 90% of the lymphoid infiltrate was composed of cytotoxic T lymphocytes, positive for CD8, Tia1, and Granzyme B. Myeloperoxidase was positive in 20% of small and medium histiocytes, which co-expressed CD68 (Fig. 1G). The uterine neoplasm showed some of the markers expressed by the nodal tumor, but it was negative for cytokeratins (CKs), EMA, and D2-40. Peripheral lymphoid tissue contains a minor population of structural and immune accessory cells, which are collectively known as reticulum cells. Three major subtypes have been identified: follicular dendritic cells, interdigitating dendritic cells, and fibroblastic reticular cells (FBRCs) (12). Tumors derived from FBRCs are very uncommon neoplasms presenting different histologic, immunohistochemical and ultrastructural characteristics, with variable biologic behavior (1–10). The immunohistochemical profile of TFBRs is heterogeneous and the different immunoprofiles may be related to the subtype of FBRCs from which the tumor arises (13). Our case was positive for vimentin and CKs, but surprisingly also for CD10, D2-40, CNA-42, CD38, WT1, and a-1-antitrypsin. This profile has not been reported previously in TFBRs but shares some features with those of some FBRCs. On this topic, we have observed in some lymph nodes (unpublished data) that CD10 was expressed in spindleor star-shaped cells localized around the venules of high endothelium in paracortical and medullar areas (Fig. 1H). Therefore, whether CD10 is found in cells with histologic features and location similar to FBRCs, it is coherent that this antigen could be present in a tumor supposedly derived of a subtype of CD10-positive FBRCs.